Explore more publications!

Sci-Tech Today: Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today: Africa.

Press releases published on February 6, 2026

Intent IQ integrates identity-driven performance at scale in Horizon Media's newly launched HorizonOS
Joveo’s 2026 Recruiting Benchmarks Report Reveals Up to 9x Growth in Applicant Volume Over the Past Three Years
BitMart Card Expands Global Reach to 115+ Countries, Unveils 2026 Benefits With Up to 5.5% Cashback and $300+ in Annual Rewards
Inspired Entertainment Launches Game-Changing Lottery Platform STRATA
Kingfisher Metals Increases Previously Announced Bought Deal Financing to C$25 Million
Nord Security has received over 400 patents
NordVPN passes its no-logs assurance assessment for the sixth time
Carahsoft and Partners to Showcase Cybersecurity, DevSecOps and AI and Machine Learning Solutions at WEST in San Diego, California, Feb. 10-12, 2026
AIM ImmunoTech to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
AI Model Advancements Do Not Alter the Quantum Threat Model — They Reinforce the Need for SEALSQ Type of Post-Quantum Secure Infrastructure
Rail Vision Advances Strategic Collaboration with Israel Railways Cargo Division
VisionWave Holdings Announces Succesful Live Demonstration of SaverOne’s (Nasdaq: SVRE) RF-Based VRU Platform
Fluent, Inc. Announces Sale of Non-Core Call Solutions Subsidiary to Accelerate Strategic Shift to High Growth Commerce Media Solutions Business
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
ESET’s Chief Security Evangelist Tony Anscombe to Speak at NetDiligence Cyber Risk Summit
Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions